FISCHER
Fischer Medical Ventures Limited (FISCHER) Stock Analysis
Fischer Medical Ventures Limited is an Indian healthcare and medical devices company. It develops or distributes medical products and services for clinical customers. The company operates in the healthcare equipment and services space. It is listed on Indian stock exchanges.
Healthcare › Medical Devices
₹29.70
-2.34% 1W | -68.40% 52W
Market Cap
2.1k CR
P/E Ratio
12.7
52W High
₹121.7
52W Low
₹29.1
Div. Yield
0.17%
Beta
0.2
50 DMA
₹35.1
200 DMA
₹37.1
Profit Margin
8.2%
Inst. Own.
2.8%
⚠️ BREAKDOWN
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 20.79 | 10.12 | 39.66 | 11.75 | 49.17 | 23.44 | 86.31 | 101.10 | 97.54 | 81.92 |
| Expenses | 0.00 | 18.28 | 10.33 | 39.16 | 11.38 | 46.66 | 19.45 | 70.09 | 79.53 | 101.31 | 70.67 |
| Operating Profit | 0.00 | 2.51 | -0.21 | 0.50 | 0.37 | 2.51 | 3.99 | 16.22 | 21.57 | -3.77 | 11.25 |
| OPM % | 12.07% | -2.08% | 1.26% | 3.15% | 5.10% | 17.02% | 18.79% | 21.34% | -3.87% | 13.73% | |
| Other Income | 0.00 | 0.47 | 0.69 | 0.05 | 0.38 | 0.15 | 7.47 | 2.48 | 1.09 | 0.77 | 1.48 |
| Interest | 0.00 | 0.05 | 0.13 | 0.05 | 0.07 | 0.23 | 0.66 | 0.92 | 0.64 | 3.66 | 3.54 |
| Depreciation | 0.00 | 0.18 | 0.28 | 0.29 | 0.56 | 0.51 | 0.77 | 0.51 | 0.77 | 0.93 | 1.36 |
| Profit before tax | 0.00 | 2.75 | 0.07 | 0.21 | 0.12 | 1.92 | 10.03 | 17.27 | 21.25 | -7.59 | 7.83 |
| Tax % | 6.18% | 271.43% | -38.10% | 350.00% | 26.04% | 51.55% | 19.46% | 9.18% | 64.03% | 51.60% | |
| Net Profit | 0.00 | 2.59 | -0.12 | 0.29 | -0.29 | 1.31 | 4.86 | 13.90 | 19.23 | -12.44 | 3.79 |
| EPS in Rs | 0.00 | 0.05 | -0.00 | 0.01 | -0.01 | 0.02 | 0.07 | 0.21 | 0.30 | -0.19 | 0.06 |
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| Sales | 0 | 21 | 111 | 308 | 367 |
| Expenses | 0 | 19 | 107 | 265 | 322 |
| Operating Profit | 0 | 2 | 3 | 43 | 45 |
| OPM % | 11% | 9% | 3.0% | 14% | 12% |
| Other Income | 0 | 0 | 1 | 12 | 6 |
| Interest | 0 | 0 | 0 | 6 | 9 |
| Depreciation | 0 | 0 | 2 | 3 | 4 |
| Profit before tax | 0 | 2 | 3 | 47 | 39 |
| Tax % | 13% | 37% | 33% | ||
| Net Profit | -0 | 2 | 1 | 31 | 24 |
| EPS in Rs | -0.24 | 0.03 | 0.02 | 0.49 | 0.38 |
| Dividend Payout % | 0% | 0% | 22% | 1% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 1,097.0% | – | – |
| Profit CAGR | 831.0% | – | – |
Shareholding Pattern
Promoters61.80%
FIIs5.57%
DIIs1.42%
Public31.22%
Promoters61.80%
FIIs4.85%
DIIs1.36%
Public31.99%
Promoters62.15%
FIIs4.97%
DIIs1.38%
Public31.51%
Promoters62.15%
FIIs5.48%
DIIs1.35%
Public31.01%
Promoters63.09%
FIIs5.57%
DIIs1.26%
Public30.09%
Public100.00%
FIIs5.07%
DIIs1.68%
Public93.24%
Promoters62.82%
FIIs5.23%
DIIs1.44%
Public30.51%
Promoters62.15%
FIIs4.97%
DIIs1.38%
Public31.51%
Promoters63.09%
FIIs5.57%
DIIs1.26%
Public30.09%
FISCHER
Holdings Analysis
Key strengths & risk signals
58
Overall
58
Fundamental
59
Technical
Risks (4)
TOO MUCH PUBLIC HOLDING! 99.99% public ownership - higher volatility risk.
POOR YEAR! Stock declined 68.4% in the last year.
WEAK POSITION! Current price (29.7) is below both moving averages.
WEAK! Trading at 0.6% of 52W range - near yearly lows.
Strengths (4)
Cannot calculate PEG - insufficient growth data.
BULLISH SENTIMENT! In last 30 days: 8 up days, 22 down days. Avg volume on up days: 1,699,046 vs down days: 541,088. Ratio: 3.14x
OVERSOLD! RSI at 28.1 - potential bounce opportunity.
LOW VOLATILITY! Beta of 0.20 - stable stock, less market risk.
Fundamental & Technical Analysis
58Overall
58Fundamental
59Technical
Fundamental Breakdown
Growth Quality
17/30
Revenue CAGR: 1097.9% (EXCELLENT, 15/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin
3/10
LOW MARGIN! 8.2% profit margin - thin profits.
PEG Valuation
10/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.17% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.25 - excellent financial health.
Public Holding
5/20
TOO MUCH PUBLIC HOLDING! 99.99% public ownership - higher volatility risk.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
5/10
BEARISH TREND! 50-day average (35.1) is below 200-day average (37.1) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (29.7) is below both moving averages.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
0/10
POOR YEAR! Stock declined 68.4% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 8 up days, 22 down days. Avg volume on up days: 1,699,046 vs down days: 541,088. Ratio: 3.14x
RSI
5/5
OVERSOLD! RSI at 28.1 - potential bounce opportunity.
52W Range
1/5
WEAK! Trading at 0.6% of 52W range - near yearly lows.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 2.3% (1 week), 11.5% (1 month), 24.5% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.20 - stable stock, less market risk.
FISCHER
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q2FY262025-11-13 | Concall PDF |
Peer Comparison
Healthcare · Medical Devices · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FISCHER | ₹29.70 | 12.7 | 8.2% | 1,097.9% | – | -68.4% | 58 | BREAKDOWN | -22.4% | -153.5% | +250.0% | -16.2% |
| UNIVPHOTO | ₹430.20 | – | -91.2% | -24.3% | – | +67.3% | 57 | BREAKDOWN | -366.5% | -445.8% | +10.0% | +19.6% |
| NURECA | ₹320.90 | 74.6 | 2.8% | 9.7% | – | +10.5% | 58 | BREAKDOWN | +287.5% | -150.8% | +17.8% | +13.8% |
| SAKAR | ₹961.70 | 69.9 | 13.3% | 22.0% | 23.0% | +190.4% | 73 | BREAKDOWN | +112.8% | -9.1% | +38.5% | +2.7% |
| SYNCOMF | ₹21.90 | 23.4 | 17.2% | 29.4% | 56.2% | +31.7% | 79 | APPROACHING SUPPORT | +57.0% | -1.6% | +7.4% | -7.3% |
| PANACEABIO | ₹359.70 | – | -1.1% | 10.1% | – | -20.0% | 48 | CONSOLIDATING DOWN | -42.5% | +360.0% | +19.7% | +19.7% |
| SAIPARENT | ₹487.30 | 168 | 3.9% | 126.1% | 111.8% | +19.3% | 67 | APPROACHING RESISTANCE | +464.3% | -1,416.7% | +435.0% | -33.6% |
| VENUSREM | ₹1,719.50 | 22.4 | 13.4% | 11.6% | 57.0% | +264.9% | 74 | BREAKDOWN | +126.2% | +85.5% | +31.2% | +43.9% |
Data from TradeAlone · Updated daily
FISCHER News
Fischer Medical Ventures Limited (fischer) Launches Next-generation Clarion 64/128-slice Ai-driven CT System2026-08-28Fischer Medical Ventures Limited (fischer) Awarded Catanduanes Digital Healthcare Project2026-08-24Fischer Medical Ventures Limited (fischer) Partners for Advanced Neurosurgical Imaging Technology2026-07-31Fischer Medical Ventures Limited Secures CDSCO Import Approval for Spincare2026-07-30Fischer Medical Ventures Limited (fischer) Announces Landmark Partnership with WFNS Innovation & Technology Committee2026-05-14
